Welcome to the Ionis Medical Grants Portal!

This platform supports the submission, review, and management of grant requests for Independent Medical Education (IME).

IME is defined as education that is evidence-based, fair-balanced, unbiased, and independent of industry influence. Therefore, all aspects related to IME including but not limited to the agenda, content, and faculty, must remain fully independent and be under the sole control of the activity organizers. Ionis will not provide any guidance to the IME provider. All accredited programs must follow the standards set forth in the ACCME Standards for Integrity and Independence in Accredited Continuing Education.

We are accepting grant applications for medical education programs within the United States for the following therapeutic areas of focus:

Hereditary Angioedema (HAE)Severe Hypertriglyceridemia including genetic conditions such as Familial Chylomicronemia Syndrome:Note Regarding Grants in the ATTR Therapeutic Area

Global and United States IME grants requests for amyloid transthyretin cardiomyopathy (ATTR-CM) and amyloid transthyretin polyneuropathy (ATTR-PM) will now be submitted to and reviewed by our global development and commercialization partner AstraZeneca. Please visit www.astrazenecagrants.com to review the application procedure and/or to submit.

Please note that the IME grant request must be submitted at least 60 calendar days prior to the program/event start date. Submission of a request does not guarantee Ionis' support.

To submit an IME grant request to Ionis, please begin by clicking the "Register" button on the top right of the page. If you are already registered, you may sign in to access your IME grant requests.

Contact Information

If you have any questions regarding the Ionis IME Grant program, please email MAGrants@ionisph.com

For Technical Support with the Ionis IME Grant Portal, please contact SteepRock Client Services via email at Support@SteepRockInc.com or phone at +1 (718) 576-1406 (M-F 8am - 6pm US ET).